Amplification of the mutation-carrying BRCA2 allele promotes RAD51 loading and PARP inhibitor resistance in the absence of reversion mutations.
Park, Pyoung Hwa, Yamamoto, Tomomi M, Li, Hua, Alcivar, Allen L, Xia, Bing, Wang, Yifan, Bernhardy, Andrea J., Turner, Kristen M, Kossenkov, Andrew V, Watson, Zachary L, Behbakht, Kian, Casadei, SilviLanguage:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-17-0256
Date:
October, 2019
File:
PDF, 10.07 MB
english, 2019